Replies to post #26281 on Biotech Values

[DewDiligence]

Aslan: do you have any comment on the second question in #msg-10362265? T.i.a.

[DewDiligence]

>Are the regulatory hurdles for drugs aimed at treating AIDS-related conditions lower?<

In general, Yes. An example is Sculptra from SNY, which is approved as a cosmetic treatment for AIDS patients but not for the general public:

http://www1.sculptra.com/US/Index.jsp

p.s. For want of a better name, I refer to the condition Sculptra treats as Chet Baker syndrome, in honor of the legendary jazzman. Anyone who has seen photos of Baker from his final years will understand what I mean.